The ROE as of December 2025 (TTM) for Simcere Pharmaceutical Group Limited (2096.HK) is 12.31%

According to Simcere Pharmaceutical Group Limited’s latest financial reports and current stock price. The company's current ROE is 12.31%. This represents a change of -1902.57% compared to the average of -0.68% of the last 4 quarters.

Simcere Pharmaceutical Group Limited (2096.HK) Historical ROE (quarterly & annually)

How has 2096.HK ROE performed in the past?

The mean historical ROE of Simcere Pharmaceutical Group Limited over the last ten years is 22.95%. The current 12.31% ROE has changed -46.37% with respect to the historical average. Over the past ten years (40 quarters), 2096.HK's ROE was at its highest in in the December 2019 quarter at 36.65%. The ROE was at its lowest in in the December 2023 quarter at -21.60%.

Simcere Pharmaceutical Group Limited (2096.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Simcere Pharmaceutical Group Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Simcere Pharmaceutical Group Limited (2096.HK) Average ROE

How has 2096.HK ROE performed in the past?

The current ROE of Simcere Pharmaceutical Group Limited (2096.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Simcere Pharmaceutical Group Limited (2096.HK) ROE vs. Peers

How is 2096.HK’s ROE compared to its peers?

Simcere Pharmaceutical Group Limited’s ROE is less than Asymchem Laboratories (Tianjin) Co., Ltd. (6.07%), less than Shanghai Henlius Biotech, Inc. (25.67%), greater than Duality Biotherapeutics, Inc. (-469.17%), less than Genscript Biotech Corporation (71.23%), less than China Medical System Holdings Limited (9.90%), less than China Resources Pharmaceutical Group Limited (5.79%), less than Livzon Pharmaceutical Group Inc. (15.39%), less than Grand Pharmaceutical Group Limited (12.37%), greater than Ascentage Pharma Group International (-249.24%), greater than Shanghai Junshi Biosciences Co., Ltd. (-15.79%),

Build a custom stock screener for Simcere Pharmaceutical Group Limited (2096.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Simcere Pharmaceutical Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Simcere Pharmaceutical Group Limited (2096.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Simcere Pharmaceutical Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.